Beskrivelse
Krav
IPC-klasse
Fullmektig i Norge:
Org.nummer: 979993269
- Org.nummer:
- Foretaksnavn:
- Foretaksform:
- Næring:
-
Forretningsadresse:
Fullmektig i EP:
2008.06.27, WO PCT/NL08/050430
BETZ A G ET AL: "Elements regulating somatic hypermutation of an immunoglobulin @k gene: Critical role for the intron enhancer/matrix attachment region", CELL, ELSEVIER, AMSTERDAM NL, vol. 77, no. 2, 22 April 1994 (1994-04-22) , pages 239-248, XP024245265, ISSN: 0092-8674, DOI: 10.1016/0092-8674(94)90316-6 [retrieved on 1994-04-22] (B1)
WOODLEY L ET AL: "REGULATION OF ALTERNATIVE PRE-MRNA SPLICING", BRIEFINGS IN FUNCTIONAL GENOMICS AND PROTEOMICS, HENRY STEWART, LONDON, GB, vol. 1, no. 3, 1 October 2002 (2002-10-01) , pages 266-277, XP001168605, ISSN: 1473-9550 (B1)
DE KRUIF JOHN ET AL: "Human immunoglobulin repertoires against tetanus toxoid contain a large and diverse fraction of high-affinity promiscuous V(H) genes.", JOURNAL OF MOLECULAR BIOLOGY 3 APR 2009, vol. 387, no. 3, 3 April 2009 (2009-04-03) , pages 548-558, XP002556330, ISSN: 1089-8638 (B1)
EP-A- 1 439 234 (B1)
EP-A2- 0 814 159 (B1)
FALKOFF R M ET AL: "T cell enrichment and depletion of human peripheral blood mononuclear cell preparations. Unexpected findings in the study of the functional activities of the separated populations", JOURNAL OF IMMUNOLOGICAL METHODS, ELSEVIER SCIENCE PUBLISHERS B.V.,AMSTERDAM, NL, vol. 50, no. 1, 16 April 1982 (1982-04-16) , pages 39-49, XP023676462, ISSN: 0022-1759, DOI: 10.1016/0022-1759(82)90302-7 [retrieved on 1982-04-16] (B1)
FATHIMA SHAMILA ET AL: "Comparison of Manual Versus Automated Data Collection Method for Haematological Parameters", BIOMEDICAL JOURNAL OF SCIENTIFIC & TECHNICAL RESEARCH, vol. 15, no. 3, 1 March 2019 (2019-03-01), XP055816823, DOI: 10.26717/BJSTR.2019.15.002702 Retrieved from the Internet: URL:https://biomedres.us/pdfs/BJSTR.MS.ID. 002702.pdf> (B1)
FAUSTINO N. A. ET AL: "Pre-mRNA splicing and human disease", GENES & DEVELOPMENT, vol. 17, no. 4, 15 February 2003 (2003-02-15), pages 419-437, XP055816814, DOI: 10.1101/gad.1048803 Retrieved from the Internet: URL:http://genesdev.cshlp.org/content/17/4 /419.full.pdf> (B1)
GOODNOW CHRISTOPHER C ET AL: "Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice", NATURE, MACMILLAN JOURNALS LTD., ETC, LONDON, vol. 334, no. 6184, 1 August 1988 (1988-08-01), pages 676-682, XP037103628, ISSN: 0028-0836, DOI: 10.1038/334676A0 [retrieved on 1988-08-01] (B1)
Horwitz David A ET AL: "Distinctive Functional Properties of Human Blood L Lymphocytes: A Comparison with T Lymphocytes, B Lymphocytes, and Monocytes", The Journal of immunology (1950), 1 May 1977 (1977-05-01), pages 1712-1721, XP055816820, United States Retrieved from the Internet: URL:https://www.jimmunol.org/content/jimmu nol/118/5/1712.full.pdf [retrieved on 2021-06-22] (B1)
Ivan J. Fuss ET AL: "Isolation of Whole Mononuclear Cells from Peripheral Blood and Cord Blood" In: "Current Protocols in Immunology", 1 May 2001 (2001-05-01), John Wiley & Sons, Inc., Hoboken, NJ, USA, XP055072167, ISBN: 978-0-47-114273-7 DOI: 10.1002/0471142735.im0701s85, (B1)
JAKOBOVITS AYA ET AL: "From XenoMouse technology to panitumumab, the first fully human antibody product from transgenic mice.", NATURE BIOTECHNOLOGY OCT 2007, vol. 25, no. 10, October 2007 (2007-10), pages 1134-1143, XP002556637, ISSN: 1087-0156 (B1)
JUDDE J-G ET AL: "Characterization of the human immunoglobulin kappa gene 3' enhancer: functional importance of three motifs that demonstrate B-cell-specific in vivo footprints", MOLECULAR AND CELLULAR BIOLOGY, AMERICAN SOCIETY FOR PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, US, vol. 12, no. 11, 1 November 1992 (1992-11-01), pages 5206-5216, XP001069601, ISSN: 0270-7306 (B1)
KERSTIN B MEYER ET AL: "The importance of the 3'-enhancer region in immunoglobulin x gene expression", NUCLEIC ACIDS RESEARCH, OXFORD UNIVERSITY PRESS, GB, vol. 18, no. 19, 11 October 1990 (1990-10-11), pages 5609-5615, XP001525496, ISSN: 0305-1048, DOI: 10.1093/NAR/18.19.5609 (B1)
L M Carlson ET AL: "Templated insertions in the rearranged chicken IgL V gene segment arise by intrachromosomal gene conversion.", GENES AND DEVELOPMENT., vol. 4, no. 4, 1 April 1990 (1990-04-01), pages 536-547, XP055654273, US ISSN: 0890-9369, DOI: 10.1101/gad.4.4.536 (B1)
LARRICK J W ET AL: "Rapid cloning of rearranged immunoglobulin genes from human hybridoma cells using mixed primers and the polymerase chain reaction", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, ELSEVIER, AMSTERDAM NL, vol. 160, no. 3, 15 May 1989 (1989-05-15), pages 1250-1256, XP000293053, ISSN: 0006-291X, DOI: 10.1016/S0006-291X(89)80138-X (B1)
LONBERG NILS: "Human antibodies from transgenic animals", NATURE BIOTECHNOLOGY, NATURE PUBLISHING GROUP, NEW YORK, NY, US, vol. 23, no. 9, 1 September 2005 (2005-09-01), pages 1117-1125, XP002442149, ISSN: 1087-0156 (B1)
PELANDA R ET AL: "A prematurely expressed Ig(kappa) transgene, but not V(kappa)J(kappa) gene segment targeted into the Ig(kappa) locus, can rescue B cell development in lambda5-deficient mice.", IMMUNITY SEP 1996, vol. 5, no. 3, September 1996 (1996-09), pages 229-239, XP002556633, ISSN: 1074-7613 (B1)
PRESTA ET AL: "Engineering of therapeutic antibodies to minimize immunogenicity and optimize function", ADVANCED DRUG DELIVERY REVIEWS, ELSEVIER BV, AMSTERDAM, NL, vol. 58, no. 5-6, 7 August 2006 (2006-08-07), pages 640-656, XP024892146, ISSN: 0169-409X [retrieved on 2006-08-07] (B1)
SIRAC C ET AL: "Role of the monoclonal k chain V domain and reversibility of renal damage in a transgenic model of acquired Fanconi syndrome", BLOOD, AMERICAN SOCIETY OF HEMATOLOGY, US, vol. 108, no. 2, 15 July 2006 (2006-07-15) , pages 536-543, XP003030514, ISSN: 0006-4971, DOI: 10.1182/BLOOD-2005-11-4419 (B1)
WEINER LOUIS M: "Fully human therapeutic monoclonal antibodies", JOURNAL OF IMMUNOTHERAPY, LIPPINCOTT WILLIAMS & WILKINS, HAGERSTOWN, MD, US, vol. 29, no. 1, 1 January 2006 (2006-01-01), pages 1-9, XP009118693, ISSN: 1524-9557 (B1)
WO-A1-02/066630 (B1)
WO-A1-2004/106375 (B1)
WO-A2-2005/068622 (B1)
WO-A2-2006/117699 (B1)
CARTEGNI L ET AL: "Listening to silence and understanding nonsense: exonic mutations that affect splicing", NATURE REVIEWS GENETICS, MACMILLAN MAGAZINES, GB, vol. 3, no. 4, 1 April 2002 (2002-04-01), pages 285-298, XP002262849, DOI: 10.1038/NRG775 (B1)
Statushistorie
Hovedstatus | Beslutningsdato, detaljstatus |
---|---|
EP patent gjort gjeldende i Norge | EP patent besluttet gjeldende i Norge |
EP under behandling | Forespørsel om å gjøre EP patent gyldig er mottatt |
Korrespondanse
Dato
Type korrespondanse
Journal beskrivelse
|
---|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Utgående
EP Varsel om betaling av første årsavgift (3319) (PTEP3456190)
|
Utgående
EP Registreringsbrev (3210) (PTEP3456190)
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende, AR475724095
Korrespondanse (Hovedbrev inn)
|
Utgående
EP formelle mangler
|
Innkommende, AR472784025
Søknadsskjema Patent
|
Innkommende
EP Publiseringsdokument fra EPO
|
Til betaling:
Betalingshistorikk:
Beskrivelse / Fakturanummer | Betalingsdato | Beløp | Betaler | Status |
---|---|---|---|---|
Årsavgift 16. avg. år (EP) | 2024.06.18 | 6760 | PAVIS PAYMENTS GMBH | Betalt og godkjent |
Årsavgift 15. avg. år (EP) | 2023.06.20 | 4850 | PAVIS PAYMENTS GMBH | Betalt og godkjent |
Årsavgift 14. avg. år (EP) | 2022.06.21 | 4500 | PAVIS PAYMENTS GMBH | Betalt og godkjent |
32201833 expand_more expand_less | 2022.02.23 | 5500 | BRYN AARFLOT AS | Betalt |
Valideringsgebyr EP-patent
5500 = 1 X 5500
|